Source link : https://www.newshealth.biz/health-news/upfront-low-dose-radiation-improves-advanced-sclc-outcomes/
Adding low-dose radiation to the current standard first-line treatment, durvalumab plus etoposide-platinum chemotherapy, appears to improve survival outcomes in patients with extensive-stage small cell lung cancer (SCLC), suggested new findings from a small, single-arm study. The analysis, presented at the 2024 European Lung Cancer Congress, revealed that low-dose radiation improved patients’ median progression-free and overall […]
Author : News Health
Publish date : 2024-03-22 10:19:20
Copyright for syndicated content belongs to the linked Source.
Categories